{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:35:32Z","timestamp":1757608532644,"version":"3.44.0"},"reference-count":25,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Sex Reprod Health"],"accepted":{"date-parts":[[2021,10,12]]},"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1136\/bmjsrh-2020-200977","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T13:20:30Z","timestamp":1635945630000},"page":"72-77","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["A case vignette describing management of menopausal symptoms and migraine in the perimenopause"],"prefix":"10.1136","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0307-7233","authenticated-orcid":false,"given":"Katherine Louise","family":"Gilmore","sequence":"first","affiliation":[{"name":"Newcastle Hospitals NHS Foundation Trust, Newcroft House, Newcroft Centre, Newcastle, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1283-1365","authenticated-orcid":false,"given":"Diana","family":"Mansour","sequence":"additional","affiliation":[{"name":"Newcastle Hospitals NHS Foundation Trust, Newcroft House, Newcroft Centre, Newcastle, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,11,3]]},"reference":[{"key":"2025090222055567000_48.1.72.1","unstructured":"Hillard T , Abernethy K , Hamoda H . Management of the menopause. 6th ed. British Menopause Society, 2017."},{"key":"2025090222055567000_48.1.72.2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/2053369120957514","article-title":"The British Menopause Society & Women's Health Concern 2020 recommendations on hormone replacement therapy in menopausal women","volume":"26","author":"Hamoda","year":"2020","journal-title":"Post Reprod Health"},{"key":"2025090222055567000_48.1.72.3","unstructured":"National Institute for Health and Care Excellence (NICE) . Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. NICE, 2013."},{"key":"2025090222055567000_48.1.72.4","unstructured":"Faculty of Sexual and Reproductive Healthcare (FSRH) Clinical Guideline . Contraception for women aged over 40 years, 2017."},{"year":"2020","key":"2025090222055567000_48.1.72.5","article-title":"Joint RCOG, BSGE and BGCS guidance for the management of abnormal uterine bleeding in the evolving coronavirus (COVID-19) pandemic"},{"key":"2025090222055567000_48.1.72.6","unstructured":"British Menopause Society . Benefits and risks of HRT before and after a breast cancer diagnosis. consensus statement, 2020."},{"key":"2025090222055567000_48.1.72.7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/2053369120956636","article-title":"The risks and benefits of hormone replacement therapy before and after a breast cancer diagnosis","volume":"26","author":"Marsden","year":"2020","journal-title":"Post Reprod Health"},{"key":"2025090222055567000_48.1.72.8","unstructured":"National Institute for Health and Care Excellence (NICE) . Guideline NG23. In: Menopause diagnosis and management. NICE, 2015."},{"key":"2025090222055567000_48.1.72.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e763"},{"key":"2025090222055567000_48.1.72.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39555.441944.BE"},{"key":"2025090222055567000_48.1.72.11","doi-asserted-by":"crossref","DOI":"10.1007\/s11940-018-0492-7","article-title":"Current treatment options: headache related to menopause \u2013 diagnosis and management","volume":"20","author":"Lauritsen","year":"2018","journal-title":"Curr Treat Options Neurol"},{"key":"2025090222055567000_48.1.72.12","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj316"},{"key":"2025090222055567000_48.1.72.13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017639"},{"key":"2025090222055567000_48.1.72.14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e6409"},{"key":"2025090222055567000_48.1.72.15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/tog.12539","article-title":"Vaginal estrogen deficiency","volume":"21","author":"Khanjani","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2025090222055567000_48.1.72.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2007.00726.x"},{"key":"2025090222055567000_48.1.72.17","unstructured":"Royal College of Obstetricians and Gynaecologists (RCOG) . Alternatives to HRT for the management of symptoms of the menopause. Scientific Impact Paper No 6. London: RCOG, 2010."},{"key":"2025090222055567000_48.1.72.18","article-title":"Phytoestrogens for menopausal vasomotor symptoms","volume":"12","author":"Lethaby","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090222055567000_48.1.72.19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1980.03310130021021"},{"key":"2025090222055567000_48.1.72.20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13697137.2020.1834530","article-title":"Neurokinin 3 receptor antagonists - prime time?","volume":"24","author":"Prague","year":"2021","journal-title":"Climacteric"},{"key":"2025090222055567000_48.1.72.21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/GME.0000000000000194","article-title":"Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women","volume":"21","author":"Walega","year":"2014","journal-title":"Menopause"},{"key":"2025090222055567000_48.1.72.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2009.12.017"},{"key":"2025090222055567000_48.1.72.23","unstructured":"Schneider HPG , Heinemann LAJ , Thiele K . The menopause rating scale (MRS): cultural and linguistic translation into English. life and medical science online, 2002. Available: https:\/\/zeg-berlin.de\/wp-content\/uploads\/2017\/01\/MRS_English.pdf"},{"key":"2025090222055567000_48.1.72.24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejogrb.2010.08.017","article-title":"A 60-month non-comparative study on bleeding profiles with the levonorgestrel intrauterine system from the late transition period to estrogen supplemented menopause","volume":"153","author":"Depypere","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025090222055567000_48.1.72.25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/2053369121989230","article-title":"Vision for menopause care in the UK","volume":"27","author":"Currie","year":"2021","journal-title":"Post Reprod Health"}],"container-title":["BMJ Sexual & Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjsrh-2020-200977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T05:06:12Z","timestamp":1756875972000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1136\/bmjsrh-2020-200977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,3]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,10]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/bmjsrh-2020-200977"],"URL":"https:\/\/doi.org\/10.1136\/bmjsrh-2020-200977","relation":{},"ISSN":["2515-1991","2515-2009"],"issn-type":[{"type":"print","value":"2515-1991"},{"type":"electronic","value":"2515-2009"}],"subject":[],"published":{"date-parts":[[2021,11,3]]}}}